Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Adam Fischer, M.D.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R18HS026177 (FISCHER, MICHAEL A.) Sep 30, 2019 - Jul 31, 2024
    AHRQ
    Demonstrating, testing, and disseminating a sustainable model for academic detailing programs
    Role: Principal Investigator
  2. R01CE003153 (FISCHER, MICHAEL A.) Sep 30, 2019 - Sep 29, 2022
    CDC/NCIPC
    Engaging clinicians to improve opioid safety and reduce overdose risk
    Role: Principal Investigator
  3. R13HS026829 (FISCHER, MICHAEL A.) Aug 1, 2019 - Jul 31, 2022
    AHRQ
    Innovation in Academic Detailing to Improve Health Care Quality and Outcomes: NaRCAD International Conference Series on Academic Detailing
    Role: Principal Investigator
  4. R13HS024651 (FISCHER, MICHAEL A) Sep 30, 2016 - Sep 29, 2019
    AHRQ
    The Role of Academic Detailing in Health Care Improvement: NaRCAD International Conference Series on Academic Detailing
    Role: Principal Investigator
  5. R18HS023236 (FISCHER, MICHAEL A) Jun 1, 2014 - May 31, 2018
    AHRQ
    Leveraging a national academic detailing resource to improve clinical decisions
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Fischer MA. Academic Detailing in Diabetes: Using Outreach Education to Improve the Quality of Care. Curr Diab Rep. 2016 10; 16(10):98. PMID: 27586191.
    Citations:    Fields:    Translation:Humans
  2. Fischer MA. Capsule commentary on Lo-Ciganic, et al., Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program. J Gen Intern Med. 2016 09; 31(9):1081. PMID: 27279099.
    Citations: 1     Fields:    Translation:Humans
  3. Liao JM, Fischer MA. Early Patterns of Sofosbuvir Utilization by State Medicaid Programs. N Engl J Med. 2015 Sep 24; 373(13):1279-81. PMID: 26398092.
    Citations: 5     Fields:    Translation:Humans
  4. Fischer MA, Jones JB, Wright E, Van Loan RP, Xie J, Gallagher L, Wurst AM, Shrank WH. A randomized telephone intervention trial to reduce primary medication nonadherence. J Manag Care Spec Pharm. 2015 Feb; 21(2):124-31. PMID: 25615001.
    Citations: 3     Fields:    Translation:Humans
  5. Fischer MA. Chipping away: improving primary medication adherence. JAMA Intern Med. 2013 Jan 14; 173(1):44-5. PMID: 23183843.
    Citations: 1     Fields:    Translation:Humans
  6. Fischer MA, Avorn J. Academic detailing can play a key role in assessing and implementing comparative effectiveness research findings. Health Aff (Millwood). 2012 Oct; 31(10):2206-12. PMID: 23048098.
    Citations: 7     Fields:    
  7. Fischer MA, Choudhry NK, Brill G, Avorn J, Schneeweiss S, Hutchins D, Liberman JN, Brennan TA, Shrank WH. Trouble getting started: predictors of primary medication nonadherence. Am J Med. 2011 Nov; 124(11):1081.e9-22. PMID: 22017787.
    Citations: 28     Fields:    Translation:Humans
  8. Shrank WH, Choudhry NK, Agnew-Blais J, Federman AD, Liberman JN, Liu J, Kesselheim AS, Brookhart MA, Fischer MA. State generic substitution laws can lower drug outlays under Medicaid. Health Aff (Millwood). 2010 Jul; 29(7):1383-90. PMID: 20606192.
    Citations: 15     Fields:    Translation:Humans
  9. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010 May; 48(5):409-17. PMID: 20393360.
    Citations: 25     Fields:    Translation:Humans
  10. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, Avorn J, Solomon D, Brookhart MA, Choudhry NK. Patient, physician, and payment predictors of statin adherence. Med Care. 2010 Mar; 48(3):196-202. PMID: 19890219.
    Citations: 54     Fields:    Translation:Humans
  11. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010 Apr; 25(4):284-90. PMID: 20131023.
    Citations: 99     Fields:    Translation:Humans
  12. Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients' perceptions of generic medications. Health Aff (Millwood). 2009 Mar-Apr; 28(2):546-56. PMID: 19276015.
    Citations: 50     Fields:    Translation:Humans
  13. Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, Avorn J, Choudhry NK. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009 Mar; 47(3):319-25. PMID: 19194329.
    Citations: 20     Fields:    Translation:Humans
  14. Fischer MA, Vogeli C, Stedman M, Ferris T, Brookhart MA, Weissman JS. Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med. 2008 Dec 08; 168(22):2433-9. PMID: 19064827.
    Citations: 21     Fields:    Translation:Humans
  15. Fischer MA, Polinski JM, Servi AD, Agnew-Blais J, Kaci L, Solomon DH. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. Arthritis Rheum. 2008 Nov 15; 59(11):1611-7. PMID: 18975371.
    Citations: 3     Fields:    Translation:Humans
  16. Fischer MA, Vogeli C, Stedman MR, Ferris TG, Weissman JS. Uptake of electronic prescribing in community-based practices. J Gen Intern Med. 2008 Apr; 23(4):358-63. PMID: 18373130.
    Citations: 14     Fields:    Translation:Humans
  17. Shrank WH, Stedman M, Ettner SL, DeLapp D, Dirstine J, Brookhart MA, Fischer MA, Avorn J, Asch SM. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med. 2007 Sep; 22(9):1298-304. PMID: 17647066.
    Citations: 19     Fields:    Translation:Humans
  18. Fischer MA, Choudhry NK, Winkelmayer WC. Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Health Aff (Millwood). 2007 May-Jun; 26(3):800-7. PMID: 17485759.
    Citations: 8     Fields:    Translation:Humans
  19. Polinski JM, Wang PS, Fischer MA. Medicaid's prior authorization program and access to atypical antipsychotic medications. Health Aff (Millwood). 2007 May-Jun; 26(3):750-60. PMID: 17485754.
    Citations: 16     Fields:    Translation:Humans
  20. Fischer MA, Morris CA, Winkelmayer WC, Avorn J. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients. Arch Intern Med. 2007 Apr 23; 167(8):840-6. PMID: 17452549.
    Citations: 1     Fields:    Translation:Humans
  21. Qureshi A, Fischer MA. Topical calcineurin inhibitors revisited. Arch Dermatol. 2007 Apr; 143(4):545-6. PMID: 17438195.
    Citations:    Fields:    Translation:Humans
  22. Fischer MA, Servi AD, Polinski JM, Wang PS. Restrictions on antidepressant medications for children: a review of Medicaid policy. Psychiatr Serv. 2007 Jan; 58(1):135-8. PMID: 17215425.
    Citations: 2     Fields:    Translation:Humans
  23. Patrick AR, Winkelmayer WC, Avorn J, Fischer MA. Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis. Pharmacoeconomics. 2007; 25(11):949-61. PMID: 17960953.
    Citations: 4     Fields:    Translation:Humans
  24. Fischer MA. The National e-Prescribing Patient Safety Initiative: removing one hurdle, confronting others. Drug Saf. 2007; 30(6):461-4. PMID: 17536873.
    Citations: 1     Fields:    Translation:Humans
  25. Winkelmayer WC, Fischer MA, Schneeweiss S, Levin R, Avorn J. Angiotensin inhibition after myocardial infarction: does drug class matter? J Gen Intern Med. 2006 Dec; 21(12):1242-7. PMID: 17105523.
    Citations: 2     Fields:    Translation:Humans
  26. Kesselheim AS, Fischer MA, Avorn J. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending. Health Aff (Millwood). 2006 Nov-Dec; 25(6):1637-47. PMID: 17102189.
    Citations: 6     Fields:    Translation:Humans
  27. Kesselheim AS, Fischer MA, Avorn J. The rise and fall of Natrecor for congestive heart failure: implications for drug policy. Health Aff (Millwood). 2006 Jul-Aug; 25(4):1095-102. PMID: 16835191.
    Citations: 5     Fields:    Translation:Humans
  28. Fischer MA, Cheng H, Schneeweiss S, Avorn J, Solomon DH. Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review. Med Care. 2006 Jul; 44(7):658-63. PMID: 16799360.
    Citations: 4     Fields:    Translation:Humans
  29. Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res. 2006 May; 21(5):765-71. PMID: 16734392.
    Citations: 22     Fields:    Translation:Humans
  30. Qureshi AA, Fischer MA. Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. Arch Dermatol. 2006 May; 142(5):633-7. PMID: 16702502.
    Citations: 2     Fields:    Translation:Humans
  31. Fischer MA, Avorn J. Educating trainees about the cost of medications. Virtual Mentor. Available at http://www.ama-assn.org/ama/pub/category/15953.html. 2006; 8:142-6.
  32. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005 Dec 01; 353(22):2335-41. PMID: 16319382.
    Citations: 190     Fields:    Translation:Humans
  33. Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7. PMID: 16310574.
    Citations: 14     Fields:    Translation:Humans
  34. Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, Glynn RJ. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005 Aug; 46(2):273-9. PMID: 15983239.
    Citations: 16     Fields:    Translation:Humans
  35. Fischer MA, Winkelmayer WC, Rubin RH, Avorn J. The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis. 2005 Aug 01; 41(3):301-7. PMID: 16007524.
    Citations: 12     Fields:    Translation:Humans
  36. Fischer MA, Schneeweiss S, Avorn J, Solomon DH. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med. 2004 Nov 18; 351(21):2187-94. PMID: 15548779.
    Citations: 29     Fields:    Translation:Humans
  37. Fischer MA, Avorn J. Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA. 2004 Apr 21; 291(15):1850-6. PMID: 15100203.
    Citations: 45     Fields:    Translation:Humans
  38. Fischer MA, Avorn J. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit. Pharmacoepidemiol Drug Saf. 2004 Apr; 13(4):207-14. PMID: 15255087.
    Citations: 19     Fields:    Translation:Humans
  39. Fischer MA, Lilly CM, Churchill WW, Baden LR, Avorn J. An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre. Drug Saf. 2004; 27(15):1253-61. PMID: 15588120.
    Citations: 3     Fields:    Translation:Humans
  40. Fischer MA, Solomon DH, Teich JM, Avorn J. Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients. Arch Intern Med. 2003 Nov 24; 163(21):2585-9. PMID: 14638558.
    Citations: 16     Fields:    Translation:Humans
  41. Fischer MA, Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res. 2003 Aug; 38(4):1051-63. PMID: 12968816.
    Citations: 17     Fields:    Translation:Humans
  42. Amaravadi RK, Jacobson BC, Solomon DH, Fischer MA. Acute pancreatitis associated with rofecoxib. Am J Gastroenterol. 2002 Apr; 97(4):1077-8. PMID: 12003405.
    Citations: 2     Fields:    Translation:Humans
  43. Fischer MA. Excess sample size and the ’Delta Wobble’ in randomized controlled trials. 1997.
  44. Fischer MA, Feinstein AR. The etymology and pathogenesis of "wonk". J Clin Epidemiol. 1995 Aug; 48(8):1089-90. PMID: 7775997.
    Citations:    Fields:    
  45. Currie J, Gruber J, Fischer M. Physician payment and infant mortality: evidence from Medicaid fee policy. American Economic Review Papers and Proceedings. 1995; 82(2):106-11.
  46. Fischer MA. Weighing the evidence: an empirical analysis of the expansions of Medicaid coverage for pregnant women, 1984-1990. 1992.
  47. Winickoff RN, Fischer MA, August BJ. Appropriateness of short-stay admissions for procedures in six Veterans Affairs hospitals. QRB Qual Rev Bull. 1991 Dec; 17(12):386-91. PMID: 1792037.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu. SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Fischer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (233)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.